Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Extel 2010

16 Jun 2010 09:19

RNS Number : 6983N
Arden Partners plc
16 June 2010
 



Arden Partners plc

("Arden" or the "Company")

Arden Partners, the institutional stockbroker, is delighted that its equity brokerage and research teams ranked highly in Extel's 2010 UK Survey. 

Fund managers voted Arden No. 1 for broking Financials (Jeremy Grime, Sarah Spikes, Peter Lenardos) and No. 3 for broking Capital Goods (Ben Thefaut, Chris Thomas, David Larkam, and Graham Webster).

Individually, Jeremy Grime and Sarah Spikes were voted the No. 1 and No. 2 analysts in Financials.

Extel 2010 is based on record participation across the professional investment community, with data and processes independently verified by Deloitte.

Commenting on the result, Jonathan Keeling, CEO of Arden said;

"We are delighted that our teams and individuals have been recognised by the buy-side community at these awards. We have a strong capability in our research department across our specialist sectors and these awards demonstrate our commitment to recruiting and retaining quality analysts and salespeople to provide leading insightful analysis."

For further information, please contact:

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

 

Buchanan Communications 020 7466 5000

Mark Edwards / Nicola Cronk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUBGQUPUURQ
Date   Source Headline
10th Nov 20104:10 pmRNSTransaction in own shares and Total Voting Rights
10th Nov 20102:56 pmRNSHolding(s) in Company
8th Nov 20101:33 pmRNSHolding(s) in Company
8th Nov 20101:06 pmRNSTransaction in own shares and Total Voting Rights
5th Nov 201010:33 amRNSTransaction in own shares and Total Voting Rights
2nd Nov 20107:00 amRNSTrading update
19th Oct 201010:39 amRNSForm 8.5 (EPT/NON-RI)
18th Oct 201011:03 amRNSForm 8.5 (EPT/NON-RI)
15th Oct 201010:49 amRNSForm 8.5 (EPT/NON-RI)
13th Oct 201011:34 amRNSForm 8.5 (EPT/NON-RI)
8th Oct 201011:08 amRNSForm 8.5 (EPT/NON-RI)
7th Oct 201011:25 amRNSForm 8.5 (EPT/NON-RI)
6th Oct 201012:33 pmRNSBoard change
6th Oct 201011:25 amRNSForm 8.5 (EPT/NON-RI)
1st Oct 201010:14 amRNSForm 8.5 (EPT/NON-RI)
30th Sep 201011:23 amRNSForm 8.5 (EPT/NON-RI)
28th Sep 20104:59 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th Sep 201010:56 amRNSForm 8.5 (EPT/NON-RI)
27th Sep 201011:28 amRNSForm 8.5 (EPT/NON-RI)
24th Sep 20103:36 pmRNSForm 8.5 (EPT/NON-RI)
10th Sep 20107:00 amRNSTrading update and Director's declaration
12th Jul 20109:58 amRNSForm 8.5 (EPT/NON-RI)
8th Jul 201010:16 amRNSForm 8.5 (EPT/NON-RI)
8th Jul 201010:14 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 201010:25 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201011:26 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 201010:19 amRNSForm 8.5 (EPT/NON-RI)
22nd Jun 20107:00 amRNSBoard Changes
22nd Jun 20107:00 amRNSInterim results for the six months ended 30 April
16th Jun 20109:19 amRNSExtel 2010
10th Jun 20109:36 amRNSForm 8.5 (EPT/NON-RI)
24th May 201011:30 amRNSForm 8.5 (EPT/NON-RI)
21st May 201012:09 pmRNSBlocklisting Return
11th May 201011:14 amRNSForm 8.5 (EPT/NON-RI)
10th May 201010:35 amRNSForm 8.5 (EPT/NON-RI)
7th May 201010:27 amRNSForm 8.5 (EPT/NON-RI)
6th May 20109:37 amRNSForm 8.5 (EPT/NON-RI)
5th May 201010:12 amRNSForm 8.5 (EPT/NON-RI)
4th May 201010:30 amRNSForm 8.5 (EPT/NON-RI)
26th Mar 20104:14 pmRNSDirector's dealing
25th Mar 20102:16 pmRNSResult of AGM
25th Mar 20107:00 amRNSAGM Statement
10th Mar 20102:55 pmRNSHolding(s) in Company
2nd Mar 201012:58 pmRNSAnnual Financial Report
1st Mar 201010:47 amRNSTotal Voting Rights
12th Feb 201012:19 pmRNSDirectors' dealings
2nd Feb 201011:20 amRNSEPT Disclosure
29th Jan 201011:21 amRNSEPT Disclosure
28th Jan 20107:00 amRNSPreliminary results for the year ended 31 October
25th Jan 201011:41 amRNSEPT Disclosure - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.